| OSQUIO BIOMARIN INTERNATIONAL LIMITED
1576630 07 May 2012 | on 27 May 2015 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of genetic diseases and disorders, namely, enzyme deficiency and bone-related disorders, achondroplasia, genetically defined cancers, namely recurrent solid tumors, acute myeloid leukemia, myelodysplastic syndrome, chronic lymphocytic leukemia, mantle cell lymphoma with identified or suspected abnormalities of DNA repair, phenylketonuria, pompe disease, mucopolysaccharidosis IVA, mucopolysaccharidosis VI and CLN2 (Batten Disease); pharmaceutical preparations for use in enzyme therapy. | | 
